Glenn Sblendorio

Glenn Sblendorio has an estimated net worth of $16.6 Million. This is based on reported shares across multiple companies, which include EYETECH PHARMACEUTICALS INC, Mineralys Therapeutics, Inc., INTERCEPT PHARMACEUTICALS, INC., AMICUS THERAPEUTICS, INC., IVERIC bio, Inc., MEDICINES CO /DE, and 4D Molecular Therapeutics, Inc..

2011 was Glenn Sblendorio's most active year for acquiring shares with 22 total transactions. Glenn Sblendorio's most active month to acquire stocks was the month of May. 2023 was Glenn Sblendorio's most active year for disposing of shares, totalling 32 transactions. Glenn Sblendorio's most active month to dispose stocks was the month of November. 2013 saw Glenn Sblendorio paying a total of $5,610,643.14 for 322,876 shares, this is the most they've acquired in one year. In 2015 Glenn Sblendorio cashed out on 399,886 shares for a total of $7,937,453.26, their largest year based on trade value.